JPH0417199B2 - - Google Patents
Info
- Publication number
- JPH0417199B2 JPH0417199B2 JP59210524A JP21052484A JPH0417199B2 JP H0417199 B2 JPH0417199 B2 JP H0417199B2 JP 59210524 A JP59210524 A JP 59210524A JP 21052484 A JP21052484 A JP 21052484A JP H0417199 B2 JPH0417199 B2 JP H0417199B2
- Authority
- JP
- Japan
- Prior art keywords
- substance
- culture
- extract
- antibiotic
- ethyl acetate
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 239000000126 substance Substances 0.000 claims description 37
- KOZFSFOOLUUIGY-SOLYNIJKSA-N K-252a Chemical compound C12=C3N4C5=CC=CC=C5C3=C3CNC(=O)C3=C2C2=CC=CC=C2N1[C@H]1C[C@@](C(=O)OC)(O)[C@]4(C)O1 KOZFSFOOLUUIGY-SOLYNIJKSA-N 0.000 claims description 36
- KOZFSFOOLUUIGY-UHFFFAOYSA-N K252a Natural products C12=C3N4C5=CC=CC=C5C3=C3CNC(=O)C3=C2C2=CC=CC=C2N1C1CC(C(=O)OC)(O)C4(C)O1 KOZFSFOOLUUIGY-UHFFFAOYSA-N 0.000 claims description 14
- 241000894006 Bacteria Species 0.000 claims description 8
- 238000004519 manufacturing process Methods 0.000 claims description 7
- 238000012258 culturing Methods 0.000 claims description 4
- 241000187362 Actinomadura Species 0.000 claims description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 33
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 21
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 10
- 210000004027 cell Anatomy 0.000 description 10
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 9
- 239000000284 extract Substances 0.000 description 9
- 238000000862 absorption spectrum Methods 0.000 description 7
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 6
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 6
- HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical compound [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 6
- 239000003242 anti bacterial agent Substances 0.000 description 6
- 229940088710 antibiotic agent Drugs 0.000 description 6
- 230000001580 bacterial effect Effects 0.000 description 6
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 6
- 238000000655 nuclear magnetic resonance spectrum Methods 0.000 description 6
- 239000004480 active ingredient Substances 0.000 description 5
- 239000013078 crystal Substances 0.000 description 5
- 239000000741 silica gel Substances 0.000 description 5
- 229910002027 silica gel Inorganic materials 0.000 description 5
- 239000002904 solvent Substances 0.000 description 5
- 241000186361 Actinobacteria <class> Species 0.000 description 4
- 229920001817 Agar Polymers 0.000 description 4
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 4
- 229920002472 Starch Polymers 0.000 description 4
- 239000008272 agar Substances 0.000 description 4
- 230000000844 anti-bacterial effect Effects 0.000 description 4
- 230000000813 microbial effect Effects 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 235000015097 nutrients Nutrition 0.000 description 4
- IOLCXVTUBQKXJR-UHFFFAOYSA-M potassium bromide Chemical compound [K+].[Br-] IOLCXVTUBQKXJR-UHFFFAOYSA-M 0.000 description 4
- 239000008107 starch Substances 0.000 description 4
- 235000019698 starch Nutrition 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 3
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 3
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 3
- 241000209140 Triticum Species 0.000 description 3
- 235000021307 Triticum Nutrition 0.000 description 3
- 238000005273 aeration Methods 0.000 description 3
- PNNNRSAQSRJVSB-BXKVDMCESA-N aldehydo-L-rhamnose Chemical compound C[C@H](O)[C@H](O)[C@@H](O)[C@@H](O)C=O PNNNRSAQSRJVSB-BXKVDMCESA-N 0.000 description 3
- 229910000019 calcium carbonate Inorganic materials 0.000 description 3
- 229940041514 candida albicans extract Drugs 0.000 description 3
- 229910052799 carbon Inorganic materials 0.000 description 3
- 239000008103 glucose Substances 0.000 description 3
- 239000002609 medium Substances 0.000 description 3
- OVARTBFNCCXQKS-UHFFFAOYSA-N propan-2-one;hydrate Chemical compound O.CC(C)=O OVARTBFNCCXQKS-UHFFFAOYSA-N 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 238000004809 thin layer chromatography Methods 0.000 description 3
- 239000012138 yeast extract Substances 0.000 description 3
- GMKMEZVLHJARHF-UHFFFAOYSA-N 2,6-diaminopimelic acid Chemical compound OC(=O)C(N)CCCC(N)C(O)=O GMKMEZVLHJARHF-UHFFFAOYSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 229920002261 Corn starch Polymers 0.000 description 2
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 2
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 2
- 239000005909 Kieselgur Substances 0.000 description 2
- 241000191938 Micrococcus luteus Species 0.000 description 2
- 239000001888 Peptone Substances 0.000 description 2
- 108010080698 Peptones Proteins 0.000 description 2
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- 230000009102 absorption Effects 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 230000000843 anti-fungal effect Effects 0.000 description 2
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- SKCNIGRBPJIUBQ-UHFFFAOYSA-N chloroform;ethyl acetate Chemical compound ClC(Cl)Cl.CCOC(C)=O SKCNIGRBPJIUBQ-UHFFFAOYSA-N 0.000 description 2
- WORJEOGGNQDSOE-UHFFFAOYSA-N chloroform;methanol Chemical compound OC.ClC(Cl)Cl WORJEOGGNQDSOE-UHFFFAOYSA-N 0.000 description 2
- 238000004440 column chromatography Methods 0.000 description 2
- 239000008120 corn starch Substances 0.000 description 2
- 229940099112 cornstarch Drugs 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 238000000921 elemental analysis Methods 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 239000002024 ethyl acetate extract Substances 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 230000007935 neutral effect Effects 0.000 description 2
- 239000006877 oatmeal agar Substances 0.000 description 2
- 235000019319 peptone Nutrition 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 239000013587 production medium Substances 0.000 description 2
- 235000020183 skimmed milk Nutrition 0.000 description 2
- VWDWKYIASSYTQR-UHFFFAOYSA-N sodium nitrate Chemical compound [Na+].[O-][N+]([O-])=O VWDWKYIASSYTQR-UHFFFAOYSA-N 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- UQZSVIGPZAULMV-DKWTVANSSA-N (2s)-2,4-diamino-4-oxobutanoic acid;propane-1,2,3-triol Chemical compound OCC(O)CO.OC(=O)[C@@H](N)CC(N)=O UQZSVIGPZAULMV-DKWTVANSSA-N 0.000 description 1
- XNWFRZJHXBZDAG-UHFFFAOYSA-N 2-METHOXYETHANOL Chemical compound COCCO XNWFRZJHXBZDAG-UHFFFAOYSA-N 0.000 description 1
- 241000187361 Actinomadura sp. Species 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- RFSUNEUAIZKAJO-VRPWFDPXSA-N D-Fructose Natural products OC[C@H]1OC(O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-VRPWFDPXSA-N 0.000 description 1
- SHZGCJCMOBCMKK-UHFFFAOYSA-N D-mannomethylose Natural products CC1OC(O)C(O)C(O)C1O SHZGCJCMOBCMKK-UHFFFAOYSA-N 0.000 description 1
- SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 description 1
- YZCKVEUIGOORGS-OUBTZVSYSA-N Deuterium Chemical compound [2H] YZCKVEUIGOORGS-OUBTZVSYSA-N 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- SRBFZHDQGSBBOR-HWQSCIPKSA-N L-arabinopyranose Chemical compound O[C@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-HWQSCIPKSA-N 0.000 description 1
- PNNNRSAQSRJVSB-UHFFFAOYSA-N L-rhamnose Natural products CC(O)C(O)C(O)C(O)C=O PNNNRSAQSRJVSB-UHFFFAOYSA-N 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 244000173804 Martynia lutea Species 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 229910002651 NO3 Inorganic materials 0.000 description 1
- NHNBFGGVMKEFGY-UHFFFAOYSA-N Nitrate Chemical compound [O-][N+]([O-])=O NHNBFGGVMKEFGY-UHFFFAOYSA-N 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- MUPFEKGTMRGPLJ-RMMQSMQOSA-N Raffinose Natural products O(C[C@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@@H](O[C@@]2(CO)[C@H](O)[C@@H](O)[C@@H](CO)O2)O1)[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 MUPFEKGTMRGPLJ-RMMQSMQOSA-N 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- MUPFEKGTMRGPLJ-UHFFFAOYSA-N UNPD196149 Natural products OC1C(O)C(CO)OC1(CO)OC1C(O)C(O)C(O)C(COC2C(C(O)C(O)C(CO)O2)O)O1 MUPFEKGTMRGPLJ-UHFFFAOYSA-N 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 239000003463 adsorbent Substances 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 1
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 1
- 235000011130 ammonium sulphate Nutrition 0.000 description 1
- 239000010775 animal oil Substances 0.000 description 1
- 229940121375 antifungal agent Drugs 0.000 description 1
- 239000012752 auxiliary agent Substances 0.000 description 1
- 239000007640 basal medium Substances 0.000 description 1
- TXHIDIHEXDFONW-UHFFFAOYSA-N benzene;propan-2-one Chemical compound CC(C)=O.C1=CC=CC=C1 TXHIDIHEXDFONW-UHFFFAOYSA-N 0.000 description 1
- 238000004166 bioassay Methods 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 210000002421 cell wall Anatomy 0.000 description 1
- 229920001429 chelating resin Polymers 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000000460 chlorine Substances 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 230000015271 coagulation Effects 0.000 description 1
- 238000005345 coagulation Methods 0.000 description 1
- 229910017052 cobalt Inorganic materials 0.000 description 1
- 239000010941 cobalt Substances 0.000 description 1
- GUTLYIVDDKVIGB-UHFFFAOYSA-N cobalt atom Chemical compound [Co] GUTLYIVDDKVIGB-UHFFFAOYSA-N 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 235000008504 concentrate Nutrition 0.000 description 1
- 239000013058 crude material Substances 0.000 description 1
- 238000012364 cultivation method Methods 0.000 description 1
- 229910052805 deuterium Inorganic materials 0.000 description 1
- 238000003113 dilution method Methods 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 239000012847 fine chemical Substances 0.000 description 1
- 235000013312 flour Nutrition 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 239000003349 gelling agent Substances 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- JYVHOGDBFNJNMR-UHFFFAOYSA-N hexane;hydrate Chemical compound O.CCCCCC JYVHOGDBFNJNMR-UHFFFAOYSA-N 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 238000004949 mass spectrometry Methods 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- XELZGAJCZANUQH-UHFFFAOYSA-N methyl 1-acetylthieno[3,2-c]pyrazole-5-carboxylate Chemical compound CC(=O)N1N=CC2=C1C=C(C(=O)OC)S2 XELZGAJCZANUQH-UHFFFAOYSA-N 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 235000013379 molasses Nutrition 0.000 description 1
- FEMOMIGRRWSMCU-UHFFFAOYSA-N ninhydrin Chemical compound C1=CC=C2C(=O)C(O)(O)C(=O)C2=C1 FEMOMIGRRWSMCU-UHFFFAOYSA-N 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 235000019198 oils Nutrition 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- XOJVVFBFDXDTEG-UHFFFAOYSA-N pristane Chemical compound CC(C)CCCC(C)CCCC(C)CCCC(C)C XOJVVFBFDXDTEG-UHFFFAOYSA-N 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 1
- MUPFEKGTMRGPLJ-ZQSKZDJDSA-N raffinose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO[C@@H]2[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O2)O)O1 MUPFEKGTMRGPLJ-ZQSKZDJDSA-N 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 description 1
- 238000011218 seed culture Methods 0.000 description 1
- 238000010898 silica gel chromatography Methods 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000004317 sodium nitrate Substances 0.000 description 1
- 235000010344 sodium nitrate Nutrition 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000000638 solvent extraction Methods 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Landscapes
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Compounds Of Unknown Constitution (AREA)
Description
産業上の利用分野
本発明は新規抗生物質SF−2370物質及びその
製造法に関するものである。
従来の技術及び発明が解決しようとする問題点
従来、種々の抗生物質が知られているが、新し
い作用をもつ新規の抗生物質を発見、製造するこ
とは常に要望されている。
問題点を解決するための手段、作用及び効果
本発明者らは各種グラム陽性菌および陰性菌に
抗菌活性を有する新規かつ有用な抗生物質を探索
した結果、アクチノマデユラ(Actinomadura)
属に属する放線菌を栄養培地中において培養する
ことにより、抗菌、抗カビ活性を有する物質が培
養物中に生産されることを見い出し、有効物質、
SF−2370物質を単離し、その理化学的性状及び
生物学的性状を確定することにより本発明を完成
した。
したがつて本発明は、下記の式:
で表わされる新規抗生物質SF−2370物質を提供
するものである。
さらに本発明は、アクチノマデユラ
(Actinomadura)属に属する抗生物質SF−2370
物質生産菌を培養し、その培養物から抗生物質
SF−2370物質を採取することを特徴とする抗生
物質SF−2370物質の製造法を提供するものであ
る。
SF−2370物質と紫外部吸収スペクトルが類似
する既知物質として、AM−2282物質(ジヤーナ
ル・オブ・アンチバイオテイツクス、第30巻、第
275〜285頁(1977年)、特公昭53−73501号公報及
び特公昭57−53076号公報)が挙げられるが、元
素分析値、分子量、赤外部吸収スペクトル及び
1H核磁気共鳴スペクトル等が異なることから、
本物質とは明療に区別される。従つてSF−2370
物質は新規物質と判定した。
本発明に使用される新規抗生物質SF−2370物
質生産菌の一例としては、本発明者らにより静岡
県清水市の土壌より新たに分離されたSF−2370
株があり、本菌株の菌学的性状はつぎのとおりで
ある。
形態
基生菌糸はよく伸長分枝し、通常の条件下では
分断しない。気菌糸の着生は一般に貧弱である
が、オートミル寒天では比較的よく着生し、胞子
形成も豊富である。気菌糸上の胞子形成はグリセ
ロール・アスパラギン寒天、スターチ寒天等でも
観察される。気菌糸の分枝は単純分枝で車軸分枝
は見られない。気菌糸先端の胞子連鎖は直状、波
状、鉤状あるいはループ状となる。
電子顕微鏡による観察では、胞子は楕円〜短円
筒型で、0.4〜0.8×0.8〜1.2μmの大きさを有し、
表面は平滑である。胞子の連鎖は10〜20程度の場
合が多い。
各種培地上の生育状態
INDUSTRIAL APPLICATION FIELD The present invention relates to a novel antibiotic SF-2370 substance and a method for producing the same. Background Art and Problems to be Solved by the Invention Various antibiotics have been known in the past, but there is always a desire to discover and produce new antibiotics with new effects. Means, Action, and Effect for Solving the Problems The present inventors searched for new and useful antibiotics that have antibacterial activity against various Gram-positive and Gram-negative bacteria, and found that Actinomadura
It was discovered that by culturing actinomycetes belonging to the genus in a nutrient medium, substances with antibacterial and antifungal activities were produced in the culture, and the effective substances,
The present invention was completed by isolating the SF-2370 substance and determining its physicochemical and biological properties. Therefore, the present invention provides the following formula: The present invention provides a novel antibiotic SF-2370 substance represented by: Furthermore, the present invention provides antibiotic SF-2370 belonging to the genus Actinomadura.
Cultivate substance-producing bacteria and extract antibiotics from the culture.
The present invention provides a method for producing an antibiotic SF-2370 substance, which comprises collecting the SF-2370 substance. AM-2282 substance (Journal of Antibiotics, Vol. 30, Vol.
275-285 (1977), Japanese Patent Publication No. 53-73501 and Japanese Patent Publication No. 57-53076), but elemental analysis values, molecular weight, infrared absorption spectrum and
Since the 1 H nuclear magnetic resonance spectra etc. are different,
It is clearly distinguished from this substance. Therefore SF−2370
The substance was determined to be a new substance. An example of the new antibiotic SF-2370 substance-producing bacteria used in the present invention is SF-2370, which was newly isolated from soil in Shimizu City, Shizuoka Prefecture by the present inventors.
The mycological properties of this strain are as follows. Morphology The basal hyphae are well elongated and branched and do not divide under normal conditions. Aerial mycelia generally adhere poorly, but on oatmeal agar they adhere relatively well and spore formation is abundant. Spore formation on aerial mycelium is also observed on glycerol-asparagine agar, starch agar, etc. The branches of the aerial hyphae are simple branches, and no axillary branches are observed. The spore chain at the tip of the aerial hyphae can be straight, wavy, hook-shaped, or loop-shaped. When observed using an electron microscope, the spores are elliptical to short cylindrical, and have a size of 0.4 to 0.8 x 0.8 to 1.2 μm.
The surface is smooth. There are often 10 to 20 spore chains. Growth status on various media
【表】
生理的性質
(1) 生育温度範囲:オートミール寒天において15
〜37℃温度範囲で生育し、25〜32℃において良
好に生育する。
(2) ゼラチンの液化:陰性(20℃、21日培養)
(3) スターチの加水分解:陰性(28℃、14日培
養)
(4) 硝酸塩の還元:陰性(28℃、14日培養)
(5) 脱脂乳のペプトン化:陽性(35℃)、陰性
(28℃)
脱脂乳の凝固:陽性(35℃)、陰性(28℃)
(6) メラニン様色素の生成:陰性
炭素源の利用性
基礎培地〔イーストエキス(Difco製)0.5%、
炭酸カルシウム0.1%、寒天(Difco製)1.5%〕
に各炭素源1%を加えて観察した。
(1)利用する:D−グルコース、D−フルクトー
ス、L−ラムノース
(2)利用しない:D−マンニトール、i−イノシト
ール、ラフイノース、シユクロース
(3)利用が疑わしい:D−キシロース、L−アラビ
ノース
細胞壁組成
全細胞加水分解物中の2,6−ジアミノピメリ
ン酸はメソ型であり、糖として少量のマデユロー
スが認められた。
以上の性状より、SF−2370株は放線菌の中で
アクチノマデユラ属に属すると考えるのが妥当で
ある。したがつて、本発明者らはSF−2370株を
アクチノマデユラ・エスピー・SF−2370
(Actinomadura sp.SF−2370)と命名した。
SF−2370株は工業技術院微生物工業技研究所
に昭和59年7月28日以来、微生物受詫番号
微工研菌寄第7760号(FERM P−7760)とし
て寄詫されている。
SF−2370株は、他の放線菌の場合にみられる
ように、その性状が変化しやすい。例えば、SF
−2370株の、またはこの株に由来する、突然変異
株(自然発生または誘発性)、形質接合体または
遺伝子組換え体であつても抗生物質SF−2370物
質を生産するものはすべて本発明に使用できる。
本発明の方法では、前記の菌を通常の微生物が
利用し得る栄養物を含有する培地で培養する。栄
養源としては、従来放線菌の培養に利用されてい
る公知のものが使用できる。例えば、炭素源とし
てグルコース、シユクロース、澱粉、グリセロー
ル、水あめ、糖みつ、動・植物油等を使用し得
る。また窒素源としては、大豆粉、小麦胚芽、肉
エキス、ペプトン、酵母エキス、コーンステイー
プリカー、硫酸アンモニウム、硝酸ソーダ等を使
用し得る。その他、必要に応じて、ナトリウム、
カリウム、カルシウム、マグネシウム、コバル
ト、塩素、燐酸、硫酸及びその他のイオンを生成
することができる可溶性無機塩類を添加すること
は有効である。また菌の発育を助け、抗生物質
SF−2370物質の生産を促進するような有機及び
無機物を適当に添加することができる。
培養物としては好気的条件下での培養法、特に
深部培養が最も適している。培養に適当な温度は
15〜37℃であるが、多くの場合26〜30℃付近で培
養する。抗生物質SF−2370物質の生産は培地や
培養条件により異なるが、振盪培養、タンク培養
ともに通常2〜10日の間でその蓄積が最高に達す
る。
本発明により得られるSF−2370物質を培養物
より採取するに当つて、その抽出精製にはアンバ
ーライトXAD−2(米国、ローム.アンド.ハー
ス社製)、ダイヤイオンHP−20(三菱化成社製)
等の合成吸着剤、セフアデツクスLH−20(スエ
ーデン国、フアルマシア・フアインケミカルズ社
製)等のゲル過剤、ヘキサンによる沈澱法、酢
酸エチル等による溶媒抽出法、シリカゲルによる
カラムクロマトグラフイー等が使用できるが、以
下による採取方法が効率的である。すなわち、培
養液より菌体その他の固型物を珪藻土等の過助
剤を用いて別し、次いで菌体中の有効成分を70
%アセトン水で抽出する。抽出液を減圧濃縮して
アセトンを留去した後、濃縮液を酢酸エチルで抽
出する。抽出液を無水硫酸ナトリウムで脱水した
後、減圧濃縮して酢酸エチルを留去し、乾固す
る。これをさらにクロロホルム−酢酸エチル
(10:1)を展開溶媒とするシリカゲルカラムク
ロマトグラフイー、メタノールを展開溶媒とする
セフアデツクスLH−20等のカラムクロマトグラ
フイーを適宜組み合わせて処理することにより、
高純度のSF−2370物質を得ることができる。
以下にSF−2370物質の理化学的性状を詳述す
る。
(1) 外 観 淡黄色結晶
(2) 元素分析値 C69.50%,H4.74%,
N8.88%
(3) 分子式 C27H21N3O5
(4) 分子量 467(質量分析、FD−MS)
(5) 融 点 256℃
(6) 比旋光度 〔α〕25 D+57゜(c0.1、メタノール)
(7) 紫外線吸収スペクトル 第1図に示すように
メタノール中で228nm(E1%
1cm725),250nm
(E1%
1cm717),265nm肩、280nm肩、
290nm(E1%
1cm1708)、320nm肩、335nm
(E1%
1cm432)、350nm(E1%
1cm325)
及び367nm(E1%
1cm353に特徴的な吸収を示す。こ
れらの吸収は酸又はアルカリを加えても、大きな
変化をしない。
(8) 赤外線吸収スペクトル 臭化カリウム錠中で
測定した赤外線吸収スペクトルは第2図に示す
とおりである。
(9) 核磁気共鳴スペクトル 重クロロホルム中で
測定した400MHz1H核磁気共鳴スペクトルを第
3図に示し、100MHz13C核磁気共鳴スペクトル
を第4図に示す。
(10) シリカゲル薄層クロマトグラフイー (キー
ゼルゲル60 F 254)
展開溶媒 Rf値
酢酸エチル 0.58
クロロホルム−メタノール(20:1) 0.63
ベンゼン−アセトン(2:1) 0.45
(11) 呈色反応
グレイグ・リーバツク(Greig−Leaback)試
薬に陽性、ニンヒドリン及び塩化第二鉄試薬に
陰性。
(12) 溶解性
ピリジン、ジメチルホルムアミド、ジメチル
スルホキシド、メチルセロソルブ及びクロロホ
ルムに可溶、メタノール、酢酸エチルに難溶、
水、n−ヘキサンに不溶である。
(13) 塩基性、酸性、中性の区分 中性
つぎにSF−2370物質の寒天平板希釈法による
抗菌、抗カビ スペクトルを第1表に示す。[Table] Physiological properties (1) Growth temperature range: 15% on oatmeal agar
It grows in a temperature range of ~37°C and grows well at 25-32°C. (2) Gelatin liquefaction: Negative (20℃, 21 days culture) (3) Starch hydrolysis: Negative (28℃, 14 days culture) (4) Nitrate reduction: Negative (28℃, 14 days culture) ( 5) Peptonization of skim milk: Positive (35℃), Negative (28℃) Coagulation of skim milk: Positive (35℃), Negative (28℃) (6) Production of melanin-like pigment: Negative Carbon source availability Basal medium [yeast extract (manufactured by Difco) 0.5%,
Calcium carbonate 0.1%, agar (manufactured by Difco) 1.5%]
1% of each carbon source was added and observed. (1) Used: D-glucose, D-fructose, L-rhamnose (2) Not used: D-mannitol, i-inositol, raffinose, sucrose (3) Suspected use: D-xylose, L-arabinose Cell wall composition 2,6-diaminopimelic acid in the whole cell hydrolyzate was in the meso form, and a small amount of madeulose was observed as a sugar. Based on the above properties, it is reasonable to consider that strain SF-2370 belongs to the genus Actinomadeura among actinomycetes. Therefore, the present inventors converted the SF-2370 strain into Actinomadeura sp. SF-2370.
(Actinomadura sp. SF-2370). Strain SF-2370 has been donated to the Institute of Microbial Technology, Agency of Industrial Science and Technology since July 28, 1981, under the microbial acceptance number FERM P-7760. The SF-2370 strain is susceptible to changes in its properties, as seen in the case of other actinomycetes. For example, S.F.
-2370 strain or derived from this strain, whether it is a mutant strain (naturally occurring or induced), a transzygote, or a genetically modified strain, which produces the antibiotic SF-2370 substance, is included in the present invention. Can be used. In the method of the present invention, the above-mentioned bacteria are cultured in a medium containing nutrients that can be utilized by common microorganisms. As the nutrient source, known nutrient sources conventionally used for culturing actinomycetes can be used. For example, glucose, sucrose, starch, glycerol, starch syrup, molasses, animal/vegetable oils, etc. can be used as carbon sources. Further, as the nitrogen source, soybean flour, wheat germ, meat extract, peptone, yeast extract, cornstarch liquor, ammonium sulfate, sodium nitrate, etc. can be used. In addition, as necessary, sodium,
It is useful to add soluble inorganic salts capable of producing potassium, calcium, magnesium, cobalt, chlorine, phosphate, sulfate and other ions. It also helps the growth of bacteria, and antibiotics
Suitable organic and inorganic substances can be added to facilitate the production of SF-2370 materials. For the culture, cultivation methods under aerobic conditions, especially deep culture, are most suitable. The appropriate temperature for culturing is
The temperature is 15-37°C, but in most cases it is cultured at around 26-30°C. Production of the antibiotic SF-2370 substance varies depending on the medium and culture conditions, but the accumulation usually reaches its maximum within 2 to 10 days in both shaking culture and tank culture. When collecting the SF-2370 substance obtained according to the present invention from a culture, its extraction and purification was carried out using Amberlite made)
Synthetic adsorbents such as, gelling agents such as Cephadex LH-20 (manufactured by Pharmacia Fine Chemicals, Sweden), precipitation with hexane, solvent extraction with ethyl acetate, column chromatography with silica gel, etc. are used. However, the following collection method is more efficient. That is, the bacterial cells and other solid substances are separated from the culture solution using a supernatant such as diatomaceous earth, and then the active ingredients in the bacterial cells are separated by 70%
Extract with % acetone water. After the extract is concentrated under reduced pressure to remove acetone, the concentrated solution is extracted with ethyl acetate. The extract is dehydrated over anhydrous sodium sulfate, concentrated under reduced pressure to remove ethyl acetate, and dried. This is further treated with an appropriate combination of silica gel column chromatography using chloroform-ethyl acetate (10:1) as a developing solvent, and column chromatography such as Sephadex LH-20 using methanol as a developing solvent.
High purity SF-2370 material can be obtained. The physical and chemical properties of SF-2370 substance are detailed below. (1) Appearance Pale yellow crystal (2) Elemental analysis values C69.50%, H4.74%, N8.88% (3) Molecular formula C 27 H 21 N 3 O 5 (4) Molecular weight 467 (mass spectrometry, FD -MS) (5) Melting point 256℃ (6) Specific optical rotation [α] 25 D +57゜ (c0.1, methanol) (7) Ultraviolet absorption spectrum 228nm (E1%) in methanol as shown in Figure 1. Absorption characteristic of 1cm725), 250nm (E1% 1cm717), 265nm shoulder, 280nm shoulder, 290nm (E1% 1cm1708), 320nm shoulder, 335nm (E1% 1cm432), 350nm (E1% 1cm325) and 367nm (E1% 1cm353) These absorptions do not change significantly even when acid or alkali is added. (8) Infrared absorption spectrum The infrared absorption spectrum measured in potassium bromide tablets is shown in Figure 2. (9) Nuclear magnetic resonance spectrum The 400MHz 1 H nuclear magnetic resonance spectrum measured in deuterated chloroform is shown in Figure 3, and the 100MHz 13 C nuclear magnetic resonance spectrum is shown in Figure 4. (10) Silica gel thin layer chromatography (Kieselgel 60 F 254) Developing solvent Rf value Ethyl acetate 0.58 Chloroform-methanol (20:1) 0.63 Benzene-acetone (2:1) 0.45 (11) Color reaction Positive for Greig-Leaback reagent, ninhydrin and chloride Negative for ferric reagents. (12) Solubility Soluble in pyridine, dimethylformamide, dimethyl sulfoxide, methyl cellosolve and chloroform, sparingly soluble in methanol and ethyl acetate.
Insoluble in water and n-hexane. (13) Classification of basic, acidic, and neutral Neutral Table 1 shows the antibacterial and antifungal spectra of the SF-2370 substance as measured by the agar plate dilution method.
【表】【table】
【表】
実施例
つぎに新抗生物質SF−2370物質の製造例を示
す。
実施例 1
グルコース2.0%、小麦胚芽1.0%、ペプトン0.5
%、酵母エキス0.5%、炭酸カルシウム0.1%を含
有する培地20ml(PH7.0)を100ml容三角フラスコ
に分注し、120℃、15分間、滅菌した。これにア
クチノマデユラ・エスピー・SF−2370(微工研菌
寄第7760号)を接種し、28℃、7日間、毎分220
回転で培養を行なつた。この培養物20mlをグルコ
ース1.5%、小麦胚芽1.0%、コーンステイープリ
カー1.0%、フアーマメデイア0.5%、炭酸カルシ
ウム0.3%からなる生産培地600ml(PH7.0)を含
む1容ジヤーフアーメンターに接種し、28℃で
5日間、通気撹拌培養(通気量毎分600ml、回転
数毎分500回転)を行なつた。培養終了後、珪藻
土を助剤に用いて過し、培養菌体を得た。この
菌体に70%アセトン水500mlを加えて有効成分を
抽出し、菌体を別した。ついで菌体抽出液を減
圧下濃縮してアセトンを留去し、得られた濃縮液
250mlに酢酸エチル250mlを加えて振盪し、有効成
分を抽出した。この抽出操作を2回くりかえし、
得られた酢酸エチル抽出液500mlを無水硫酸ナト
リウムで乾燥後、減圧下濃縮して油状物質を得
た。この油状物にn−ヘキサンを加え、生じた沈
澱を取して粗物質286mgを得た。この粗物質を
クロロホルム−酢酸エチル(10:1)混液に溶解
し、シリカゲルC−200(和光純薬工業社製)60ml
のカラムにかけ、クロロホルム−酢酸エチル
(10:1)混液600mlで展開した。展開液はシリカ
ゲル薄層クロマトグラフイー(メルク社・キーゼ
ルゲル、60 F 254,5714;展開溶媒:酢酸エチ
ル)を行ない、紫外線(254nm)を照射してRf
値を0.58を示し、サルシナ・ルテア(Sarcina
lutea)を被験菌とするペーパー・デイスク法に
よる生物検定で抗菌活性を示す分画を集め、減圧
下濃縮乾固して216mgの淡黄色粉末を得た。この
粗粉末を酢酸エチルに溶解して分取用シリカゲル
薄層クロマトグラフイー(メルク社製キーゼルゲ
ル60 F 254,5744、展開溶媒:酢酸エチル)を
行ない、活性部分(Rf値0.58)をかきとり、酢酸
エチルで抽出した。抽出液を減圧濃縮後、メタノ
ールを加えて一夜放置すると、SF−2370物質の
淡黄色結晶79mgが得られた。
実施例 2
実施例1に記載したと同様にして得られたアク
チノマデユラ・エスピー・SF−2370の種培養物
1をそれぞれ前記生産培地35を含む50容ジ
ヤーフアーメンター2基に接種し、28℃で5日間
通気撹拌培養(通気量毎分35、回転数毎分200
回転)を行なつた。培養終了後、培養物を過し
て得られた菌体に70%アセトン水25を加えて有
効成分を抽出する操作を2回行ない、菌体を別
して抽出液50を得た。この抽出液を減圧下濃縮
してアセトンを留去し、得られた濃縮液に酢酸エ
チル30を加え、15分間撹拌して有効成分を抽出
した。酢酸エチル抽出液を無水硫酸ナトリウムで
乾燥後、減圧下濃縮して淡黄色粗結晶33gを得
た。この粗結晶をクロロホルム−メタノール混液
から再結晶を2回くり返してSF−2370物質の淡
黄色結晶15gを得た。[Table] Example Next, an example of manufacturing the new antibiotic SF-2370 substance is shown. Example 1 Glucose 2.0%, wheat germ 1.0%, peptone 0.5
%, yeast extract 0.5%, and calcium carbonate 0.1% (PH 7.0) was dispensed into a 100 ml Erlenmeyer flask and sterilized at 120° C. for 15 minutes. This was inoculated with Actinomadeura sp. SF-2370 (Feikoken Bacteria No. 7760), and was heated at 28°C for 7 days at a rate of 220 m/min.
Culture was performed by rotation. 20 ml of this culture was placed in a 1 volume jar fermentor containing 600 ml of production medium (PH 7.0) consisting of 1.5% glucose, 1.0% wheat germ, 1.0% cornstarch liquor, 0.5% firma media, and 0.3% calcium carbonate. The cells were inoculated and cultured with aeration at 28° C. for 5 days (aeration volume: 600 ml/min, rotation speed: 500 revolutions/min). After the culture was completed, diatomaceous earth was used as an auxiliary agent to obtain cultured bacterial cells. 500 ml of 70% acetone water was added to the bacterial cells to extract the active ingredient, and the bacterial cells were separated. Then, the bacterial cell extract was concentrated under reduced pressure to remove acetone, and the resulting concentrated liquid was
250 ml of ethyl acetate was added to 250 ml and shaken to extract the active ingredient. Repeat this extraction operation twice,
500 ml of the obtained ethyl acetate extract was dried over anhydrous sodium sulfate and concentrated under reduced pressure to obtain an oily substance. N-hexane was added to this oil and the resulting precipitate was collected to obtain 286 mg of crude material. This crude substance was dissolved in a mixture of chloroform and ethyl acetate (10:1), and 60 ml of silica gel C-200 (manufactured by Wako Pure Chemical Industries, Ltd.) was added.
column and developed with 600 ml of a chloroform-ethyl acetate (10:1) mixture. The developing solution was subjected to silica gel thin layer chromatography (Merck & Co., Kieselgel, 60 F 254, 5714; developing solvent: ethyl acetate) and irradiated with ultraviolet light (254 nm) to obtain Rf.
Sarcina lutea (Sarcina lutea) shows a value of 0.58.
Fractions showing antibacterial activity in a paper-disc bioassay using M. lutea as the test bacterium were collected and concentrated to dryness under reduced pressure to obtain 216 mg of pale yellow powder. This crude powder was dissolved in ethyl acetate and subjected to preparative silica gel thin layer chromatography (Merck Kieselgel 60 F 254, 5744, developing solvent: ethyl acetate), the active portion (Rf value 0.58) was scraped off, and acetic acid Extracted with ethyl. After concentrating the extract under reduced pressure, methanol was added and left overnight to obtain 79 mg of pale yellow crystals of SF-2370 substance. Example 2 Seed culture 1 of Actinomadeura sp. SF-2370 obtained in the same manner as described in Example 1 was inoculated into two 50-volume jar fermenters each containing 35 of the above production medium, and incubated at 28°C. Aerated agitation culture for 5 days (aeration rate 35/min, rotation speed 200/min)
rotation). After the cultivation was completed, 25% of 70% acetone water was added to the microbial cells obtained by straining the culture to extract the active ingredients twice, and the microbial cells were separated to obtain an extract of 50%. This extract was concentrated under reduced pressure to remove acetone, and 30 ml of ethyl acetate was added to the resulting concentrate and stirred for 15 minutes to extract the active ingredients. The ethyl acetate extract was dried over anhydrous sodium sulfate and concentrated under reduced pressure to obtain 33 g of pale yellow crude crystals. The crude crystals were recrystallized twice from a chloroform-methanol mixture to obtain 15 g of pale yellow crystals of SF-2370 substance.
第1図は抗生物質SF−2370物質のメタノール
中での紫外部吸収スペクトルを示し、第2図は
SF−2370物質の臭化カリウム錠中での赤外部吸
収スペクトルを示し、第3図はSF−2370物質の
重クロロホルム中で測定した400MHz1H核磁気共
鳴スペクトルを示し、第4図はSF−2370物質の
重クロロホルム中で測定した100MHz13C核磁気共
鳴スペクトルを示す。
Figure 1 shows the ultraviolet absorption spectrum of the antibiotic SF-2370 substance in methanol, and Figure 2 shows the ultraviolet absorption spectrum of the antibiotic SF-2370 substance in methanol.
Figure 3 shows the infrared absorption spectrum of SF-2370 substance in potassium bromide tablets, Figure 3 shows the 400MHz 1 H nuclear magnetic resonance spectrum of SF-2370 substance measured in deuterated chloroform, and Figure 4 shows the SF-2370 substance measured in deuterium chloroform. This shows the 100MHz 13 C nuclear magnetic resonance spectrum of substance 2370 measured in deuterated chloroform.
Claims (1)
する抗生物質SF−2370物質生産菌を培養し、そ
の培養物から抗生物質SF−2370物質を採取する
ことを特徴とする抗生物質SF−2370物質の製造
法。[Claims] 1. The following formula: A novel antibiotic SF-2370 substance represented by 2. A method for producing an antibiotic SF-2370 substance, which comprises culturing an antibiotic SF-2370 substance-producing bacterium belonging to the genus Actinomadura, and collecting the antibiotic SF-2370 substance from the culture.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP59210524A JPS6188885A (en) | 1984-10-09 | 1984-10-09 | Novel antibiotic substance sf-2370 and its preparation |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP59210524A JPS6188885A (en) | 1984-10-09 | 1984-10-09 | Novel antibiotic substance sf-2370 and its preparation |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS6188885A JPS6188885A (en) | 1986-05-07 |
JPH0417199B2 true JPH0417199B2 (en) | 1992-03-25 |
Family
ID=16590789
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP59210524A Granted JPS6188885A (en) | 1984-10-09 | 1984-10-09 | Novel antibiotic substance sf-2370 and its preparation |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS6188885A (en) |
-
1984
- 1984-10-09 JP JP59210524A patent/JPS6188885A/en active Granted
Also Published As
Publication number | Publication date |
---|---|
JPS6188885A (en) | 1986-05-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JPS6254433B2 (en) | ||
JPS6220984B2 (en) | ||
JPS61247396A (en) | Production of genisteine | |
JPH0417199B2 (en) | ||
JPH0740950B2 (en) | Microbial production of nicotianamine | |
JP2592468B2 (en) | Benanomycins A and B, novel antibiotics and their production | |
JPH0625095B2 (en) | Antibiotic SF-2415 substance and its production method | |
JPS59170092A (en) | Novel antibiotic, ss8201d and its preparation | |
JPH05380B2 (en) | ||
JP2933451B2 (en) | New microorganism and method for producing red pigment by new microorganism | |
JPH0331195B2 (en) | ||
JPS62186787A (en) | Novel microorganism | |
JPS6015318B2 (en) | New antibiotic SF-1942 substance, its manufacturing method and anticancer agent containing it | |
JPS63154695A (en) | Novel antibiotic substance sf2446 and production thereof | |
US3532714A (en) | Antifungal agents | |
JP3380595B2 (en) | Novel antibiotics SF2741A and SF2741B and their production | |
JPH0398591A (en) | New antibiotic substance having antitumor activity and production thereof | |
JPH0479892A (en) | Production of fr-901228 substance | |
JPH046720B2 (en) | ||
JPS63201195A (en) | Antibiotic tm-611b | |
JPS63107993A (en) | Antibiotic substance tm-611 | |
JPS6232199B2 (en) | ||
JPH0411535B2 (en) | ||
JPS644516B2 (en) | ||
JPS6244915B2 (en) |